Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates.
| Last: | $19.19 |
|---|---|
| Change Percent: | 4.18% |
| Open: | $18.94 |
| Close: | $18.42 |
| High: | $19.55 |
| Low: | $18.78 |
| Volume: | 27,284 |
| Last Trade Date Time: | 02/27/2026 12:59:33 pm |
| Market Cap: | $517,254,478 |
|---|---|
| Float: | 24,899,668 |
| Insiders Ownership: | 0.01% |
| Institutions: | 20 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.altoneuroscience.com |
| Country: | US |
| City: | Mountain View |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Alto Neuroscience Inc. (NYSE: ANRO).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
